Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Ironwood Pharmaceuticals →

  company in Cambridge, United States

  • Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.Sat 10:54

Related events

• Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.Aug 31
• SynAct Pharma AB is seeking discussion with the FDA regarding the design of its Phase 3 clinical trials.Sep 7
• Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.Aug 18
• EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.Jun 8
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7